We recently published a list of 12 Best Stocks to Invest in for a Stock Market Game. In this article, we are going to take a ...

In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report), with a ...

Akebia Therapeutics, Inc.’s AKBA share price has surged by 11.37%, which has investors questioning if this is right time to ...

Akebia Therapeutics, Inc.’s AKBA share price has dipped by 28.17%, which has investors questioning if this is right time to ...

(RTTNews) - Akebia Therapeutics (AKBA), a biopharmaceutical company focused on kidney disease, Thursday has priced its underwritten public offering of 25 million common stock shares at $2.00 per ...

CAMBRIDGE, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Shares of AKBA opened at $2.55 on Monday. The company has a 50-day simple ...

Get Akebia Therapeutics alerts: Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The biopharmaceutical company reported ($0.10 ...

Short interest in Akebia Therapeutics Inc (NASDAQ:AKBA) decreased during the last reporting period, falling from 14.98M to 14.88M. This put 6.89% of the company's publicly available shares short.

March 06, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans ... Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives ...